Omarigliptin (MK-3102) Clinical Trial - Placebo- and Sitagliptin-Controlled Monotherapy Study in Japanese Patients With Type 2 Diabetes Mellitus (MK-3102-020)

NCT01703221 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

414

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Omarigliptin
DRUG: Sitagliptin
DRUG: Placebo to omarigliptin
DRUG: Placebo to sitagliptin

Sponsor

Merck Sharp & Dohme LLC